Logo del repository
  1. Home
 
Opzioni

Everolimus-based therapy in patients with hormone receptor-positive, HER2<sup>-</sup> advanced breast cancer: Management considerations

Del Mastro, Lucia
•
Cazzaniga, Marina
•
Solidoro, Paolo
altro
De Placido, Sabino
2015
  • journal article

Periodico
FUTURE ONCOLOGY
Abstract
Everolimus-based therapy in patients with hormone receptor-positive, HER2(-) advanced breast cancer: management considerations
DOI
10.2217/fon.15.134
WOS
WOS:000359635700002
Archivio
http://hdl.handle.net/11368/2904213
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84939154661
http://www.futuremedicine.com/doi/abs/10.2217/fon.15.134
Diritti
closed access
license:digital rights management non definito
FVG url
https://arts.units.it/request-item?handle=11368/2904213
Soggetti
  • adverse event

  • breast cancer

  • compliance

  • dosing

  • everolimu

  • management

  • multidisciplinary fol...

  • toxicity

  • Antineoplastic Combin...

  • Breast Neoplasm

  • Disease Management

  • Everolimu

  • Female

  • Human

  • Medication Adherence

  • Neoplasm Staging

  • Receptor, ErbB-2

  • Receptors, Estrogen

  • Receptors, Progestero...

  • Oncology

  • Cancer Research

Scopus© citazioni
2
Data di acquisizione
Jun 14, 2022
Vedi dettagli
Web of Science© citazioni
2
Data di acquisizione
Mar 25, 2024
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback